Wegovy is made by Novo Nordisk, the Danish pharmaceutical company renowned for its leadership in diabetes and obesity treatments. Wegovy—which contains the active ingredient semaglutide—is a brand-name injectable medication approved for chronic weight management. Novo Nordisk also produces related medications such as Ozempic and Rybelsus (Wikipedia, wegovy.com).
Here’s a quick snapshot:
- Novo Nordisk is the developer and manufacturer of Wegovy. It markets the drug worldwide under this brand name (Wikipedia, wegovy.com).
- Wegovy was first approved in the U.S. in 2021 and subsequently launched in various markets including Thailand in 2025 (Reuters, AP News).
So, in summary: Wegovy is manufactured and marketed by Novo Nordisk.
Let me know if you’d like to explore more about how it’s produced, its availability, or how it compares with other weight-loss therapies!
